Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calcipotriol Plus Hydrocortisone in Psoriasis Vulgaris on the Face and on the Intertriginous Areas

NCT00691002 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00691002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00691002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calcipotriol Plus Hydrocortisone in Psoriasis Vulgaris on the Face and on the Intertriginous Areas
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2008
Completion date
January 31, 2010
Enrollment
1,245 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris